Theraflu Extra Lemon 650mg+10mg+20mg powder for oral solution with lemon flavour

Šalis: Armėnija

kalba: anglų

Šaltinis: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Veiklioji medžiaga:

paracetamol, phenylephrine (phenylephrine hydrochloride), pheniramine (pheniramine maleate)

Prieinama:

Famar Orleans

ATC kodas:

N02BE51

INN (Tarptautinis Pavadinimas):

paracetamol, phenylephrine (phenylephrine hydrochloride), pheniramine (pheniramine maleate)

Dozė:

650mg+10mg+20mg

Vaisto forma:

powder for oral solution with lemon flavour

Vienetai pakuotėje:

(10) sachets 15g

Recepto tipas:

OTC

Autorizacija statusas:

Registered

Leidimo data:

2019-06-05

Prekės savybės

N O V A R T I S
Global Drug Regulatory Affairs
THERAFLU EXTRA LEMON
Powder in Sachets
Actives substances
Paracetamol 650mg; Pheniramine maleate 20mg;
Phenylephrine hydrochloride 10mg;
SUMMARY OF PRODUCT CHARACTERISTICS
Property of Novartis Consumer Health
SA Confidential
May not be used, divulged, published or otherwise
disclosed without the consent of Novartis Consumer Health
SA
TABLE OF CONTENTS
1.
NAME OF THE MEDICINAL PRODUCT
.........................................................................
3
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
.............................................. 3
3.
PHARMACEUTICAL FORM
..............................................................................................
3
4.
CLINICAL PARTICULARS
.................................................................................................
3
4.1 THERAPEUTIC INDICATIONS
................................................................................................
3
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
................................................................... 3
4.3.
CONTRAINDICATIONS
.......................................................................................................
3
4.4.
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
.................................................... 4
4.5.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION ......... 4
4.6.
PREGNANCY AND LACTATION
.............................................................................................
5
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
............................................................ 5
4.8.
UNDESIRABLE EFFECTS
.......................................................................................................6
4.9.
OVERDOSE
.......................................................................................................................
6
5.
PHARMACOLOGICAL PROPERTIES
..............................................................................
7
5.1.
PHARMACODYNA